Lapiteronel (CFG920) is an orally active, nonsteroidal, reversible dual CYP17 and CYP11B2 inhibitor. Lapiteronel has the potential for metastatic castration-resistant prostate cancer research[1][2].
Molecular Weight:
288.73
Purity:
98.51
CAS Number:
[1260006-20-9]
Formula:
C14H13ClN4O
Target:
Cytochrome P450
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
